Chang‐Hee Hong
Papers
2
Total Citations
26
H-Index
2
About
Chang-Hee Hong is a leading urological researcher whose work bridges surgical oncology and neurovascular regeneration. His research focuses on improving outcomes in renal and prostate cancer surgery, particularly through the management of postoperative complications and the preservation of erectile function. In a landmark 2019 study analyzing over 2,000 partial nephrectomies, Hong provided critical insights into the management of postoperative bleeding via selective artery embolization, using propensity score matching to deliver robust clinical guidance—a work that has garnered 16 citations for its practical impact on surgical safety. More recently, Hong has pioneered neuroprotective strategies in urology. His 2020 investigation into erectile dysfunction following radical prostatectomy demonstrated that neutralizing antibodies to proNGF can rescue erectile function by regulating neurotrophic and angiogenic factors in a mouse model of cavernous nerve injury. This 10-cited study opens new avenues for treating nerve damage caused by prostate surgery, moving beyond traditional surgical refinements to molecular intervention. Hong’s work uniquely combines large-scale clinical analysis with translational neuroscience, positioning him as a key figure in advancing both the safety and quality of life outcomes for urological patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2